Items where SHU Author is "Miller, Keith"

CHIRILA, Paula, SKIBINSKI, Lauren, MILLER, Keith, HAMILTON, Alexander and WHITEOAK, Christopher (2018). Towards a Sequential One-Pot Preparation of 1,2,3-Benzotriazin-4(3H)-ones Employing a Key Cp*Co(III)-catalyzed C-H Amidation Step. Advanced Synthesis & Catalysis, 360 (12), 2324-2332.

LIU, Gaomin, YANG, Fan, LI, Fangfang, LI, Zhongjie, LANG, Yange, SHEN, Bingzheng, WU, Yingliang, LI, Wenxin, HARRISON, Patrick L., STRONG, Peter N., XIE, Yingqiu, MILLER, Keith and CAO, Zhijian (2018). Therapeutic potential of a scorpion venom-derived antimicrobial peptide and its homologs against antibiotic-resistant gram-positive bacteria. Frontiers in Microbiology, 9, p. 1159.

HARRISON, Patrick L., HEATH, George R., JOHNSON, Benjamin R.G., ABDEL-RAHMAN, Mohamed A., STRONG, Peter, EVANS, Stephen D. and MILLER, Keith (2016). Phospholipid dependent mechanism of smp24, an α-helical antimicrobial peptide from scorpion venom. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1858 (11), 2737-2744.

CODJOE, Francis Samuel (2016). Detection and characterisation of carbapenem-resistant gram-negative bacilli infections in Ghana. Doctoral, Sheffield Hallam University.

HARRISON, Patrick L., ABDEL-RAHMAN, Mohamed A., STRONG, Peter, TAWFIK, Mohamed M. and MILLER, Keith (2016). Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus. Toxicon, 117, 30-36.

HARRISON, Patrick L, ABDEL-RAHMAN, Mohamed, MILLER, Keith and STRONG, Peter (2014). Antimicrobial peptides from scorpion venoms. Toxicon, 88, 115-137.

HARRISON, Patrick Liam. (2014). The identification and characterisation of antimicrobial peptides from snake and scorpion venom. Doctoral, Sheffield Hallam University (United Kingdom)..

KHAN, Akram, MILLER, Keith, RAINSFORD, Kim and ZHOU, Yong (2013). Synthesis and Antimicrobial Activity of Novel Substituted Ethyl 2-(Quinolin-4-yl)-propanoates. Molecules, 18 (3), 3227-3240.

KHAN, M., MILLER, Keith, RAINSFORD, Kim and ZHOU, Yong (2013). Synthesis and antimicrobial activity of novel substituted Ethyl 2-(Quinolin-4-yl)-propanoates. Molecules, 18 (3), 3227-3240.

MILLER, K., DUNSMORE, C. J., LEEDS, J. A., PATCHING, S. G., SACHDEVA, M., BLAKE, K. L., STUBBINGS, W. J., SIMMONS, K. J., HENDERSON, P. J. F., DE LOS ANGELES, J., FISHWICK, C. W. G. and CHOPRA, I. (2010). Benzothioxalone derivatives as novel inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferases (MurA and MurZ). Journal of Antimicrobial Chemotherapy, 65 (12), 2566-2573.

MARINER, K R, TROWBRIDGE, R, AGARWAL, A K, MILLER, Keith, O'NEILL, A J, FISHWICK, C W and CHOPRA, I (2010). Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymerase. Antimicrobial Agents and Chemotherapy, 54 (10), 4506-4509.

OOI, N, MILLER, Keith, RANDALL, C, RHYS-WILLIAMS, W, LOVE, W and CHOPRA, I (2010). XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. Journal of Antimicrobial Chemotherapy, 65 (1), 72-78.

OOI, N., MILLER, K., HOBBS, J., RHYS-WILLIAMS, W., LOVE, W. and CHOPRA, I. (2009). XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity. Journal of Antimicrobial Chemotherapy, 64 (4), 735-740.

DUNSMORE, C. J., MILLER, K., BLAKE, K. L., PATCHING, S. G., HENDERSON, P. J. F., GARNETT, J. A., STUBBINGS, W. J., PHILLIPS, S. E. V., PALESTRANT, D. J. and ANGELES, J. de L. (2008). 2-Aminotetralones: Novel inhibitors of MurA and MurZ. Bioorganic & Medicinal Chemistry Letters, 18 (5), 1730-1734.

HOBBS, J K, MILLER, Keith, O'NEILL, A J and CHOPRA, I (2008). Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 62 (5), 1003-1008.

MILLER, K., O'NEILL, A. J., WILCOX, M. H., INGHAM, E. and CHOPRA, I. (2008). Delayed Development of Linezolid Resistance in Staphylococcus aureus following Exposure to Low Levels of Antimicrobial Agents. Antimicrobial Agents and Chemotherapy, 52 (6), 1940-1944.

DRIFFIELD, K, MILLER, Keith, BOSTOCK, J M, O'NEILL, A J and CHOPRA, I (2008). Increased mutability of Pseudomonas aeruginosa in biofilms. Journal of Antimicrobial Chemotherapy, 61 (5), 1053-1056.

MILLER, K., DUNSMORE, C. J., FISHWICK, C. W. G. and CHOPRA, I. (2008). Linezolid and Tiamulin Cross-Resistance in Staphylococcus aureus Mediated by Point Mutations in the Peptidyl Transferase Center. Antimicrobial Agents and Chemotherapy, 52 (5), 1737-1742.

CHOPRA, I, SCHOFIELD, C, EVERETT, M, ONEILL, A, MILLER, Keith, WILCOX, M, FRERE, J, DAWSON, M, CZAPLEWSKI, L, URLEB, U and COURVALIN, P (2008). Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. The Lancet Infectious Diseases, 8 (2), 133-139.

DRIFFIELD, Kiersten L, BOSTOCK, Julieanne M, MILLER, Keith, O'NEILL, Alexander J, HOBBS, Joanne K and CHOPRA, Ian (2006). Evolution of extended-spectrum β-lactamases in a MutS-deficient Pseudomonas aeruginosa hypermutator. The Journal of antimicrobial chemotherapy, 58 (4), 905-907.

MILLER, Keith, STOREY, Christopher, STUBBINGS, William J, HOYLE, Anthony M, HOBBS, Joanne K and CHOPRA, Ian (2005). Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175). The Journal of antimicrobial chemotherapy, 55 (4), 579-582.

MILLER, Keith, O'NEILL, Alexander John and CHOPRA, Ian (2004). Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infections. Antimicrobial agents and chemotherapy, 48 (1), 23-29.

CHOPRA, Ian, O'NEILL, Alexander J and MILLER, Keith (2003). The role of mutators in the emergence of antibiotic-resistant bacteria. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 6 (3), 137-145.

MILLER, Keith, O'NEILL, Alexander John and CHOPRA, Ian (2002). Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. The Journal of antimicrobial chemotherapy, 49 (6), 925-934.